StatOrigin open statistical archive
Industries Indicators Regions Rankings Reports Compare Sources

Clinical development drug pipeline assets count

Total count of active drug candidates in clinical development.

Unit Count Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
1
Regions
1
Period
2026
Sources
1
Verification 1 verified data points Verified 17 Sep 2026 Next update Update cycle: irregular

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Clinical development drug pipeline assets count

Global, as of 28 Jul 2026

1 observation
62 Global · as of 28 Jul 2026 · GSK · full record
Source: GSK · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2026

Download CSV JSON series
Clinical development drug pipeline assets count: every record, grouped by region, newest first.
Period Value Source Type
Global 1 record
as of 28 Jul 2026 62 GSK · 28 Jul 2026 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026 GSK — 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Clinical development drug pipeline assets count. Retrieved from https://statorigin.org/indicators/clinical-development-drug-pipeline-assets-count

Download CSV Get this data as JSON Compare with… API docs